Metro Atlanta's MiMedx to spin out subsidiary to focus on biopharma
August 21, 2017 at 12:38 PM EDT
MiMedx's said its transition into a biopharmaceutical company was an impetus for its divestiture.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.